Norman Barrett: So Close, Yet 50 Years Away from the Truth

Journal of Gastrointestinal Surgery

Volumn 3, Issue 1, 1999, Pages 7-14

  Chandrasoma, Parakrama ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033439746     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(99)80002-X     Document Type: Conference Paper

References (21)

1. Tileston W. Peptic ulcer of the esophagus. Am J Med Sci 1906;132:240-265.
2. Barrett NR. Chronic peptic ulcer of the oesophagus and "oesophagitis." Br J Surg 1950;38:175-182.
3. Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax 1953;8:87-101.
4. Barrett NR. The lower esophagus lined by columnar epithelium. Surgery 1957;41:881-894.
5. Moersch RN, Ellis FH, McDonald JR. Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet 1959;108:476-484.
6. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-480.
7. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-993.
8. Spechler SJ. Esophageal columnar metaplasia (Barrett's esophagus). Gastrointest Endosc Clin North Am 1197;7:1-18.
9. Blot WJ, Devessa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the lower esophagus and gastric cardia. JAMA 1991;265:1287-1289.
10. Hayward J. The lower end of the oesophagus. Thorax 1961; 16:36-41.
11. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-143.
12. Öberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac tnucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226:522-532.
13. Spechler SJ, Wang HH, Chen YY, et al. Inflammation of the gastric cardia and H. pylori infections are not risk factors for intestinal metaplasia at the esophagogastric junction. Gastroenterology 1997;112-A297.
14. Clark GW, Ireland AP, Chandrasoma P, et al. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: A new marker for gastroesophageal reflux disease. Gastroenterology 1994;106:A63.
15. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux. Incidence and precipitating factors. Dig Dis Sci 1976;21:955-959.
16. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-hour esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87:1102-1111.
17. Csendes A, Maluenda F, Braghetto I, et al. Location of the lower oesophageal sphincter and the squamous columnar mucosa junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis. Gut 1993;34:21-27.
18. Spechler SJ, Wang HH, Chen YY, et al. GERD versus H. pylori infections as potential causes of inflammation in the gastric cardia. Gastroenterology 1997;112:A297.
19. Reid BJ, Blount PL, Rubin CE, et al. Flow cytometric and histologic progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-1219.
20. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;107:945-949.
21. Barthlen W, Liebermann-Meffert D, Feussner H, et al. Influence of pH on bile acid concentration in human, pig and commercial bile: Implications for "alkaline" gastro-esophageal reflux. Dis Esophagus 1994;7:127-130.